Join the club for FREE to access the whole archive and other member benefits.

Second Sight

Second Sight develops, manufactures and markets implantable visual prosthetics

The recognized global leader in neuromodulation devices to treat blindness, the company leverages its 20 years of technology innovation to develop devices to treat the broadest population of sight-impaired individuals. Inspired by personal connections with a retinitis pigmentosa diagnosis, Second Sight has researched, designed and created the world’s first FDA and CE Mark approved device for providing artificial vision in people with late-stage RP.

Visit website: https://www.secondsight.com/

 SecondSightArgus

 second-sight-medical-products

 Argus_BionicEye

 UCftIdIT1ENB3sqX1DF2gM3g

Details last updated 06-Dec-2019

Second Sight Creations

Argus II

Retinal prosthesis system.

Orion

First product approved by FDA for artificial vision

Second Sight News

Lights go off for people with obsolete Second Sight retinal implants

BBC - 17-Feb-2022

No promised upgrades, and no vision at all for some recipients

Read more...

Restoring sight by sending signals directly to the brain

MIT Technology Review - 06-Feb-2020

Scientists still need to understand how long electrodes can last without degrading

Read more...

You don’t even need to have eyes for this bionic eye to work

OneZero - 18-Nov-2019

Brain implant is composed of 60 electrodes which sit on the visual cortex

Read more...

iBionics' Diamond Eye has 4x resolution of Argus II

The Globe and Mail - 22-Apr-2018

iBionics is working to improve the effectiveness of vision-restoring technology. Diamond Eye imp...

Read more...

Blind Patients to Test Bionic Eye Brain Implants

MIT Technology Review - 18-Sep-2017

The company, Second Sight, is launching a clinical trial for a brain implant designed to restore...

Read more...

Becoming Cyborg: 10 Amazing MedTech Inventions

Labiotech - 15-Dec-2015

Some of the best developments from 2015: Google contact lens with wireless chip and glucose sens...

Read more...